Australian Government's Controversial Guidelines on E-Cigarettes

Jul.03.2022
Australian Government's Controversial Guidelines on E-Cigarettes
The NHMRC released a statement on e-cigarettes, but it was criticized by CAPHRA as misleading and harmful.

The National Health and Medical Research Council (NHMRC) has recently released a statement from its CEO regarding electronic cigarettes, offering guidance for public health decision-makers in 2022.

 

According to the Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA), a recent document falsely claimed that e-cigarettes were not effective smoking cessation tools, but rather a gateway to smoking. The document also asserted that most e-cigarette users became dual users, and that e-cigarettes increased the risk of smoking relapse. CAPHRA stated that the National Health and Medical Research Council (NHMRC) overemphasized the negative health effects, toxicity, and explosion risks of e-cigarettes, while failing to compare toxins and potential harm to smoking in a fair manner.

 

Nancy Loucas, coordinator for CAPHRA, stated that the latest government document regarding e-cigarettes contains outrageous false statements that will only lead to more Australian smokers losing their lives.

 

It is absurd that the Chief Medical Officer of Australia considers e-cigarettes to be the next biggest health issue after COVID-19. Has he not heard that smoking kills over 20,000 Australians each year? This 18-page document is a complete joke, filled with statements that can easily be debunked by international scientific and human evidence, says Loucas.

 

CAPHRA has stated that Australia's aggressive approach against e-cigarettes is increasingly out of sync with other Asia-Pacific countries. The Philippines, Malaysia, and Thailand are set to lift their bans on e-cigarettes. Furthermore, New Zealand has implemented a regulatory framework in Tasman, which has resulted in a decrease in smoking rates.

 

Loucas stated, "This shocking document is not something that should be put in writing, but it is now considered the bible for public health guidance in Australia and its surrounding regions.

 

Selling, supplying, or possessing nicotine e-cigarette products is illegal in Australia, the only western democracy that requires a prescription to use e-cigarettes. Shockingly, 2.3 million Australians continue to use traditional cigarettes.

 

Last year, the Australian Therapeutic Goods Administration expanded its prescription-only mode, and customs cracked down on individuals importing nicotine e-cigarette oil from overseas websites at the borders.

 

This article contains excerpts or reproductions of content sourced from third-party information, and the copyright belongs to the original media and authors. If there is any infringement, please contact us to delete it. Any organization or individual who wishes to repost it should contact the author instead of reposting it directly.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
Virginia Commonwealth University has signed a letter of intent to acquire Altria Group’s 450,000-square-foot building in downtown Richmond for USD 150 million, but the deal still depends on approval from the General Assembly. The university said the facility would support expansion of the Massey Comprehensive Cancer Center and help grow enrollment in its new School of Public Health and School of Pharmacy. VCU also said constructing a comparable facility would cost about USD 715 million.
Mar.13 by 2FIRSTS.ai
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT said it will begin rolling out “EVO Sakura Regular,” a new product under the premium EVO brand for the heated tobacco brand Ploom, at convenience stores and tobacco retailers across Japan from April 6. The product has already been on sale since February 3 through the CLUB JT online shop and Ploom Shops nationwide.
Mar.13 by 2FIRSTS.ai
Virginia Restricts Vape Sales to Products Listed in State Directory From April 1
Virginia Restricts Vape Sales to Products Listed in State Directory From April 1
From April 1, vape shops in Virginia may sell only liquid nicotine and vapor products listed in the state directory. The Office of the Attorney General has recommended that commonwealth attorneys begin enforcing the 2024 law.
Apr.02 by 2FIRSTS.ai
Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group A/S has issued notice of its annual general meeting, which will be held on April 15, 2026 at 4:30 p.m. in Copenhagen and will also be available by live webcast.
Mar.25 by 2FIRSTS.ai
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan, Ph.D., has been named a 2026 Fellow of the Society for Research on Nicotine and Tobacco (SRNT), an international professional association dedicated to advancing nicotine and tobacco research. Fellows are selected for outstanding research contributions as well as leadership, mentoring, and policy engagement within the field.
Feb.23